AONC
PINK American Oncology Network, Inc. Class A$11.00 ↑ +0.00 (+0.00%) Trading Up from the previous close of $11.00, and at the day’s high of $11.00
- YTD change
- +10.11%
- vs 20-day SMA
- N/A
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+3.10 (+39.24%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 21.1% away from all-time highs of $13.95
- AONC is up 10% since the beginning of the year
- AONC is up 10% over the past 12 months
- AONC is up 10% over the past 1 month
- 0% of all AONC investors are betting against AONC
AONC reads n/a: the 12-month move is +29.4%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +10.11%
- vs 8-day SMA
- N/A
No alerts for AONC in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
American Oncology Network, Inc. engages in the provision of community-based oncology management. The firm provides various services to patients, including laboratory services for routine and specialized testing, in-house professional and technical pathology services with pathology reports, in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance, and care management support services, including nutrition guidance. The company was founded in 2018 and is headquartered in Fort Myers, FL.
Competitor comparison
| Ticker | Company | Price | Change |
|---|---|---|---|
| PGPHF | Partners Group Holding AG | $730.00 | -3.33% |
| SEGXF | SEGRO plc | $12.00 | -4.00% |
| PHYS.U.CAT | SPROTT PHYSICAL GOLD TRUST USD | $31.17 | -0.95% |
| CPAMF | CapitaLand Integrated Commercial Trust | $1.75 | +0.00% |
| NLY | Annaly Capital Management, Inc. | $18.50 | -1.07% |
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.